Capital CS Group »

Catalyst Pharmaceutical Partners shares owned by Capital CS Group

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Capital CS Group from 13F filings

Historical chart of Capital CS Group investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Capital CS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Capital CS Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $337k 15k 23.34

More positions owned by Capital CS Group

United Parcel Service CL B (UPS)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Exchng Traded Fd Vi Ft Vest Us Equit (UXOC)
First Tr Exchng Traded Fd Vi Smith Unconstrai (UCON)
Unity Software (U)
Listed Fds Tr Roundhill Magnif (MAGS)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Series Trust State Street Spd (BIL)
Amazon (AMZN)
Spdr Series Trust State Street Spd (JNK)

View all positions for Capital CS Group

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Fundsmith
American Century Companies
Dimensional Fund Advisors
Geode Capital Management
Renaissance Technologies
Royce & Associates
Arrowstreet Capital, Limited Partnership
Millennium Management
Charles Schwab Investment Management
Invesco
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners